In case Donald Trump wasn’t already having a bad day, he can certainly cross billionaire Mark Cuban off his list of potential meaningful endorsements, after the Shark Tank alum publicly lambasted the scandal-plagued former president as a “snake oil salesman” before throwing his influential support behind incumbent President Joe Biden.
There’s no denying that Biden is struggling in the polls right now, with the 2024 election right around the corner, as questions and concerns swirl regarding the current Democratic president’s age, cognitive abilities, and his handling of the Israel-Gaza conflict.
However, this endorsement from one of America’s most high-profile businessmen should certainly give him a boost, as Cuban not only lifted President Biden, but absolutely trashed his Republican, ex-presidential opponent.
In an email sent to Axios today, Cuban matter-of-factly stated, “I don’t want a snake oil salesperson as President. I’m voting for Biden/Harris over Trump all day every day.”
Stay up-to-date with the latest news!
Subscribe and start recieving our daily emails.
“It’s the snake oil salesperson vs the incumbent, traditional politician,” Cuban stated, going on to add, “One will tell you his snake oil will cure everything that ails you. The other will show you the details of his policies through charts, graphs and statements.”
Speaking of President Biden, the billionaire businessman said, “He is precise and methodical and wants to sell the steak. Not the sizzle,” whereas, “Trump voters are happy with their snake oil whether it works or not.”
Cuban’s newest remarks to Axios serve as an expansion on his recent statement that he would support and vote for President Biden, even if Joe were on his literal death bed.
“If they were having his last wake, and it was him versus Trump, and he was being given last rites, I would still vote for Joe Biden,” Cuban told Bloomberg this week, following a White House meeting regarding perscription drug costs.
Cuban, a tech billionaire and Dallas Mavericks minority owner, is the co-owner of the Cost Plus Drugs company, founded in 2022, with the aim of lowering the prices for generic drugs.
You can read the full report from Axios here.
Featured image via Flickr/Gage Skidmore, under Creative Commons license 2.0
